MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41366-020-00694-1

Медицинская библиотека · International journal of obesity (2005) · 2020

Type 2 diabetes is associated with impaired jejunal enteroendocrine GLP-1 cell lineage in human obesity.

Osinski Céline, Le Gléau Léa, Poitou Christine, de Toro-Martin Juan, Genser Laurent, Fradet Magali, Soula Hédi Antoine, Leturque Armelle, Blugeon Corinne, Jourdren Laurent, Hubert Edwige Ludiwyne, Clément Karine, Serradas Patricia, Ribeiro Agnès

Клиническое исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVES

Altered enteroendocrine cell (EEC) function in obesity and type 2 diabetes is not fully understood. Understanding the transcriptional program that controls EEC differentiation is important because some EEC types harbor significant therapeutic potential for type 2 diabetes.

METHODS

EEC isolation from jejunum of obese individuals with (ObD) or without (Ob) type 2 diabetes was obtained with a new method of cell sorting. EEC transcriptional profiles were established by RNA-sequencing in a first group of 14 Ob and 13 ObD individuals. EEC lineage and densities were studied in the jejunum of a second independent group of 37 Ob, 21 ObD and 22 non obese (NOb) individuals.

RESULTS

The RNA seq analysis revealed a distinctive transcriptomic signature and a decreased differentiation program in isolated EEC from ObD compared to Ob individuals. In the second independent group of ObD, Ob and NOb individuals a decreased GLP-1 cell lineage and GLP-1 maturation from proglucagon, were observed in ObD compared to Ob individuals. Furthermore, jejunal density of GLP-1-positive cells was significantly reduced in ObD compared to Ob individuals.

CONCLUSIONS

These results highlight that the transcriptomic signature of EEC discriminate obese subjects according to their diabetic status. Furthermore, type 2 diabetes is associated with reduced GLP-1 cell differentiation and proglucagon maturation leading to low GLP-1-cell density in human obesity. These mechanisms could account for the decrease plasma GLP-1 observed in metabolic diseases.

Для цитирования: Osinski Céline, Le Gléau Léa, Poitou Christine, de Toro-Martin Juan, Genser Laurent, Fradet Magali, Soula Hédi Antoine, Leturque Armelle, Blugeon Corinne, Jourdren Laurent, Hubert Edwige Ludiwyne, Clément Karine, Serradas Patricia, Ribeiro Agnès. Type 2 diabetes is associated with impaired jejunal enteroendocrine GLP-1 cell lineage in human obesity.. International journal of obesity (2005). 2020. DOI: 10.1038/s41366-020-00694-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.